New Delhi, Dec 23 (IANS) A phase 1 randomised clinical trial of a novel Nipah virus vaccine, led by US researchers, may soon pave the way to prevent the deadly infection.All three doses and regimens of the vaccine named HeV-sG-V demonstrated to be safe and generated an immune response, according to the researchers in the study published in the journal The Lancet.”The induction of antibodies within 1 month of vaccination, along with the persistence afforded by two dosages, suggests the vaccine ca…
Trending
- Lo Naveena Review: Humour, Heartbreak, and Friendship Shine in This Charming Kannada Entertainer
- Sattendru Maarudhu Vaanilai Review: Jai and Meenakshi Govindarajan Deliver a Wildly Entertaining Tamil Thriller You Cannot Miss
- Shikhandi (2026) Review: A Riveting Paranormal Thriller That Awakens Ancient Legends
- Sherr (2026) Movie Review: A Raw Kannada Crime Drama That Packs a Punch
- Mr. Work From Home Review: Trigun’s Bold Leap From Silicon Valley to Soil Strikes a Meaningful Chord
- Harudu (2026) Review: Venkat’s Gritty Cop Drama Delivers Raw Action and Solid Entertainment
- Kartavya Review: Saif Ali Khan Delivers a Gripping Performance in This Bold Caste-Crime Thriller on Netflix
- Karuppu Review: Suriya’s God Mode Delivers a Rousing Mass Entertainer That Hits Where It Matters Most